Your session is about to expire
← Back to Search
RESTORE Training for End-of-Life Discussions in Cancer Care (RESTORED Trial)
N/A
Recruiting
Led By Oren Levine, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
RESTORED Trial Summary
This trial aims to create an effective communication skills curriculum for oncology residents to help them better address difficult conversations with cancer patients.
Who is the study for?
This trial is for medical and radiation oncology residents and fellows at McMaster University, as well as medical oncology residents at the Universities of Ottawa and Toronto. Participants must be enrolled in these programs, speak English, have internet access, and a video-enabled computer.Check my eligibility
What is being tested?
The study tests a remote communication skills curriculum called RESTORE aimed at improving end-of-life discussions by oncology residents. It's a preliminary study to see if it's feasible to do a larger trial comparing different training methods.See study design
What are the potential side effects?
Since this trial focuses on education and training without medical interventions, there are no direct physical side effects associated with participation.
RESTORED Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment rubric for 'entrustable professional activities' (EPAs)
COM-ON (Communication in Oncology) Checklist
Global rating scale
+1 moreSecondary outcome measures
End-of-Life Professional Caregiver Survey (EPCS)
RESTORED Questionnaire
RESTORED Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ELMs and virtual SP encountersExperimental Treatment2 Interventions
A virtual communication curriculum featuring electronic learning modules (ELMs) and skills sessions with standardized patients (SPs) along with coaching feedback.
Group II: ELMs aloneActive Control1 Intervention
A virtual communication curriculum featuring electronic learning modules (ELMs) only.
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,788 Total Patients Enrolled
Oren Levine, MDPrincipal InvestigatorMcMaster University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be enrolled in a qualifying program, able to take part in study activities conducted in English, have access to the internet and possess video-enabled computing technology for academic purposes.You are a medical and radiation oncology resident or fellow at McMaster University, or a medical oncology resident at either the University of Ottawa or Toronto.
Research Study Groups:
This trial has the following groups:- Group 1: ELMs and virtual SP encounters
- Group 2: ELMs alone
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical study actively recruiting new participants?
"As per the information available on clinicaltrials.gov, this experiment is presently enrolling participants. The trial was initially posted online on January 1st 2023 and had its latest amendments made on March 30th 2023."
Answered by AI
How many individuals are currently engaging in this research endeavor?
"Affirmative. The clinicaltrials.gov website shows that this research study, which was originally posted on January 1st 2023, is currently recruiting patients and has recently been edited on March 30th 2023. 40 people are needed from a single site for the trial to be successful."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger